DA VINCY trial: optimal Duration of Aprepitant therapy for nausea and Vomiting INduced by ChEmotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial
The (cost)effectiveness of neoadjuvant FOLFIRINOX versus upfront surgery for (borderline) resectable pancreatic cancer.
Leiden Thrombosis Risk Prevention: Tailored treatment after a first venous thromboembolism (L-TRiP study) Leiden Thrombosis Risk Prevention: Tailored treatment after a first venous thromboembolism (L-TRiP study)
Individualized PeMetRexed dOsing in lung cancER and mesothelioma patients to improVE treatment response and allow treatment of patients with impaired renal function – The IMPROVE study (previous acronym: PROPER study).
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial)
Improvement of quality of life with home dialysis compared to in-centre haemodialysis? The DOMESTICO project Improvement of quality of life with home dialysis compared to in-centre haemodialysis? The DOMESTICO project
Tailored intervention focused on self-management and acceptance to improve adherence of patients with haemophilia using prophylactic home treatment. Tailored intervention focused on self-management and acceptance to improve adherence of patients with haemophilia using prophylactic home treatment
TailoRing anti-androgEn therapy For metastatic castration resistant prostate cancer based on early tumor response markers In combiNation with drug Exposure measurement (REFINE-project)
Optimalization of Eculizumab/Soliris® treatment in patients with atypical hemolytic uremic syndrome by means of individually-tailored, personalized therapy.
Patient guided dose reduction strategy of Tyrosine Kinase Inhibitors in chronic myeloid leukemia: rodeo study
Pharmacokinetic boosting of olaparib to improve exposure, tolerance and cost-effectiveness (PROACTIVE)
